Lidocaine 2% Injectable Solution — Competitive Intelligence Brief

Lidocaine 2% Injectable Solution (Lidocaine 2% Injectable Solution) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Anesthesia.

marketed Local anesthetic Voltage-gated sodium channels Anesthesia Small molecule

Target snapshot

Lidocaine 2% Injectable Solution (Lidocaine 2% Injectable Solution) — Erasme University Hospital. Lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials to produce local anesthesia.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Lidocaine 2% Injectable Solution TARGET	Lidocaine 2% Injectable Solution	Erasme University Hospital	marketed	Local anesthetic	Voltage-gated sodium channels
local infiltration of liposomal bupivacaine	local infiltration of liposomal bupivacaine	TriHealth Inc.	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels
local anesthetic cream	local anesthetic cream	Yuzuncu Yil University	marketed	Local anesthetic	Voltage-gated sodium channels
Prilocaine 0.66%	Prilocaine 0.66%	Bozyaka Training and Research Hospital	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels
Ropivacaine + Dexmedetomidine	Ropivacaine + Dexmedetomidine	Sahiwal medical college sahiwal	marketed	Local anesthetic + alpha-2 adrenergic agonist combination	Voltage-gated sodium channels (ropivacaine); alpha-2 adrenergic receptors (dexmedetomidine)
Ropivacaine only	Ropivacaine only	University of New Mexico	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
postoperative 0.5% Ropivacaine hydrochloride	postoperative 0.5% Ropivacaine hydrochloride	China Medical University, China	marketed	Local anesthetic (amide)	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

1. University of California, San Diego · 3 drugs in this class
2. Durect · 3 drugs in this class
3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
4. Wake Forest University Health Sciences · 3 drugs in this class
5. Medical University of Vienna · 3 drugs in this class
6. Imperial College London · 2 drugs in this class
7. Hvidovre University Hospital · 2 drugs in this class
8. Innocoll · 2 drugs in this class
9. George Washington University · 2 drugs in this class
10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class